MPC-1304, another type of dihydropyridine, possessing highly potent vasodilating action
- 20 July 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 238 (2-3) , 139-148
- https://doi.org/10.1016/0014-2999(93)90841-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Antihypertensive Effects of MPC-1304, a Novel Calcium Antagonist, in Experimental Hypertensive Rats and DogsJournal of Cardiovascular Pharmacology, 1992
- Synthesis of asymmetric 4-aryl-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylates with vasodilating and antihypertensive activities.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Calcium Dependency of Vasoconstriction Mediated by α1- and α2-AdrenoceptorsJournal of Cardiovascular Pharmacology, 1985
- Influence of Bay k 8644 on Pressor Effects of B-HT 920 and Cirazoline in Pithed CatsJournal of Cardiovascular Pharmacology, 1985
- Calcium Entry Blockade and Alpha-Adrenergic Responsiveness In VivoJournal of Cardiovascular Pharmacology, 1985
- Novel dihydropyridines with positive inotropic action through activation of Ca2+ channelsNature, 1983
- Specific binding of [3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazemBiochemical and Biophysical Research Communications, 1982
- The interaction of [3H]nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of ratsBiochemical and Biophysical Research Communications, 1982
- Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium propertiesLife Sciences, 1981
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973